ond

Bi/ond is a Dutch biotechnology company specializing in advanced organ-on-chip (OOC) technologies designed to bridge the gap between biology and engineering. Founded in 2017 as a spin-off from Delft University of Technology, the company develops customizable microfluidic platforms that mimic human physiology to improve drug testing accuracy and reduce reliance on animal models. Its core products, such as the inCHIPit and MUSbit chips, enable researchers to culture 3D tissues and monitor biological responses in real-time. Bi/ond collaborates with leading pharmaceutical companies and academic institutions to advance personalized medicine and drug discovery across therapeutic areas including oncology and cardiology.